These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37173831)

  • 1. Computational identification and analysis of deleterious non-synonymous single nucleotide polymorphisms (nsSNPs) in the human
    Kumar R; Jayaraman M; Ramadas K; Chandrasekaran A
    J Biomol Struct Dyn; 2024; 42(3):1518-1532. PubMed ID: 37173831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms.
    Burkhard FZ; Parween S; Udhane SS; Flück CE; Pandey AV
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):38-50. PubMed ID: 27068427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase.
    Nurhafizuddin M; Azizi A; Ming LC; Shafqat N
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase.
    Flück CE; Nicolo C; Pandey AV
    Fundam Clin Pharmacol; 2007 Aug; 21(4):399-410. PubMed ID: 17635179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight into the structural and functional analysis of the impact of missense mutation on cytochrome P450 oxidoreductase.
    Kumar R; Jayaraman M; Ramadas K; Chandrasekaran A
    J Mol Graph Model; 2020 Nov; 100():107708. PubMed ID: 32805558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational algorithmic and molecular dynamics study of functional and structural impacts of non-synonymous single nucleotide polymorphisms in human DHFR gene.
    Alam MS; Saleh MA; Mozibullah M; Riham AT; Solayman M; Gan SH
    Comput Biol Chem; 2021 Dec; 95():107587. PubMed ID: 34710812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype.
    McCammon KM; Panda SP; Xia C; Kim JJ; Moutinho D; Kranendonk M; Auchus RJ; Lafer EM; Ghosh D; Martasek P; Kar R; Masters BS; Roman LJ
    J Biol Chem; 2016 Sep; 291(39):20487-502. PubMed ID: 27496950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of the most deleterious non-synonymous SNPs in the human IL1B gene: evidence from bioinformatics analyses.
    Abuzaid O; Idris AB; Yılmaz S; Idris EB; Idris LB; Hassan MA
    BMC Genom Data; 2024 Jun; 25(1):56. PubMed ID: 38858637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational screening of pathogenic missense nsSNPs in heme oxygenase 1 (HMOX1) gene and their structural and functional consequences.
    Yadav AK; Murthy TPK; Divyashri G; Prasad N D; Prakash S; Vaishnavi V V; Shukla R; Singh TR
    J Biomol Struct Dyn; 2024 Jul; 42(10):5072-5091. PubMed ID: 37434323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 oxidoreductase deficiency caused by R457H mutation in POR gene in Chinese: case report and literature review.
    Bai Y; Li J; Wang X
    J Ovarian Res; 2017 Mar; 10(1):16. PubMed ID: 28288674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in cytochrome P450 oxidoreductase and its effect on drug metabolism and efficacy.
    Gong L; Zhang CM; Lv JF; Zhou HH; Fan L
    Pharmacogenet Genomics; 2017 Sep; 27(9):337-346. PubMed ID: 28731962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in human drug metabolizing cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 activities caused by genetic variations in cytochrome P450 oxidoreductase.
    Velazquez MNR; Parween S; Udhane SS; Pandey AV
    Biochem Biophys Res Commun; 2019 Jul; 515(1):133-138. PubMed ID: 31128914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the most damaging nsSNPs in the human CFL1 gene and their functional and structural impacts on cofilin-1 protein.
    Halder SK; Rafi MO; Shahriar EB; Albogami S; El-Shehawi AM; Daullah SMMU; Himel MK; Emran TB
    Gene; 2022 Apr; 819():146206. PubMed ID: 35092861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics of human P450 oxidoreductase.
    Pandey AV; Sproll P
    Front Pharmacol; 2014; 5():103. PubMed ID: 24847272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrapolating the effect of deleterious nsSNPs in the binding adaptability of flavopiridol with CDK7 protein: a molecular dynamics approach.
    George Priya Doss C; Nagasundaram N; Chakraborty C; Chen L; Zhu H
    Hum Genomics; 2013 Apr; 7(1):10. PubMed ID: 23561625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico analyses of Wnt1 nsSNPs reveal structurally destabilizing variants, altered interactions with Frizzled receptors and its deregulation in tumorigenesis.
    Mondal A; Paul D; Dastidar SG; Saha T; Goswami AM
    Sci Rep; 2022 Sep; 12(1):14934. PubMed ID: 36056132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency.
    Jin Y; Chen M; Penning TM; Miller WL
    Biochem J; 2015 May; 468(1):25-31. PubMed ID: 25728647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of molecular signatures and molecular dynamics simulation of highly deleterious missense variants of key autophagy regulator beclin 1: a computational based approach.
    Kaur S; Vashistt J; Changotra H
    J Biomol Struct Dyn; 2024 Nov; 42(18):9691-9704. PubMed ID: 37640005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational identification of pathogenic associated nsSNPs and its structural impact in UROD gene: a molecular dynamics approach.
    Doss CG; Magesh R
    Cell Biochem Biophys; 2014 Nov; 70(2):735-46. PubMed ID: 24777812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of structurally and functionally high-risk nsSNPs impacts on human bone morphogenetic protein receptor type IA (BMPR1A) by computational approach.
    Islam MJ; Parves MR; Mahmud S; Tithi FA; Reza MA
    Comput Biol Chem; 2019 Jun; 80():31-45. PubMed ID: 30884445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.